These findings are in line with previous studies showing that pro-inflammatory biomarkers such as IL-1b, IL-2, IL-6, IL-12, and TNF-a increase in cancer patients following a period of sleep disruption (Mantovani et al., 2008; Jensen et al., 2021; Tucker et al., 2021). This evidence concerns the gene IL1B and cancer.